115 related articles for article (PubMed ID: 9106619)
41. Induction of delta-aminolevulinic acid synthetase during erythroid differentiation of cultured leukemia cells.
Ebert PS; Ikawa Y
Proc Soc Exp Biol Med; 1974 Jun; 146(2):601-4. PubMed ID: 4525098
[No Abstract] [Full Text] [Related]
42. Tumor promoter-mediated inhibition of cell differentiation: suppression of the expression of erythroid functions in murine erythroleukemia cells.
Fibach E; Gambari R; Shaw PA; Maniatis G; Reuben RC; Sassa S; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1906-10. PubMed ID: 287029
[TBL] [Abstract][Full Text] [Related]
43. Translational control of 5-aminolevulinate synthase mRNA by iron-responsive elements in erythroid cells.
Melefors O; Goossen B; Johansson HE; Stripecke R; Gray NK; Hentze MW
J Biol Chem; 1993 Mar; 268(8):5974-8. PubMed ID: 8449958
[TBL] [Abstract][Full Text] [Related]
44. Expression of coproporphyrinogen oxidase and synthesis of hemoglobin in human erythroleukemia K562 cells.
Taketani S; Furukawa T; Furuyama K
Eur J Biochem; 2001 Mar; 268(6):1705-11. PubMed ID: 11248690
[TBL] [Abstract][Full Text] [Related]
45. Effect of heme on globin messenger RNA synthesis.
Fuchs O; Hradilek A; Borová J; Neuwirt J; Trávnícek M
Acta Biol Med Ger; 1981; 40(7-8):915-25. PubMed ID: 6949418
[TBL] [Abstract][Full Text] [Related]
46. Comparative effects of 3'-azido-3'-deoxythymidine and its metabolite 3'-amino-3'-deoxythymidine on hemoglobin synthesis in K-562 human leukemia cells.
Weidner DA; Bridges EG; Cretton EM; Sommadossi JP
Mol Pharmacol; 1992 Feb; 41(2):252-8. PubMed ID: 1538705
[TBL] [Abstract][Full Text] [Related]
47. C-Jun modulates apoptosis but not terminal cell differentiation in murine erythroleukemia cells.
Poindessous-Jazat V; Augery-Bourget Y; Robert-Lézénès J
Leukemia; 2002 Feb; 16(2):233-43. PubMed ID: 11840290
[TBL] [Abstract][Full Text] [Related]
48. The phosphatase inhibitors, orthovanadate and levamisole, inhibit induction of erythroid differentiation and abrogate the associated inhibition of glycolysis.
Scher BM; Fuksina I; Hellinger N; Waxman S; Scher W
Int J Oncol; 1998 May; 12(5):987-96. PubMed ID: 9538118
[TBL] [Abstract][Full Text] [Related]
49. Differential effect of camptothecin treatment on topoisomerase II alpha expression in ML-1 and HL-60 leukemia cell lines.
Nair J; Traganos F; Tse-Dinh YC
Anticancer Res; 2000; 20(6B):4183-8. PubMed ID: 11205246
[TBL] [Abstract][Full Text] [Related]
50. Alteration of phosphotyrosine-containing proteins at the early stage of erythroid differentiation of mouse erythroleukemia (MEL) cells.
Watanabe T; Kume T; Oishi M
J Biol Chem; 1992 Aug; 267(24):17116-20. PubMed ID: 1380959
[TBL] [Abstract][Full Text] [Related]
51. Cytoplasmic synthesis of globin RNA in differentiated murine erythroleukemia cells: possible involvement of RNA-dependent RNA polymerase.
Volloch V
Proc Natl Acad Sci U S A; 1986 Mar; 83(5):1208-12. PubMed ID: 3456580
[TBL] [Abstract][Full Text] [Related]
52. Protein kinase clk/STY is differentially regulated during erythroleukemia cell differentiation: a bias toward the skipped splice variant characterizes postcommitment stages.
García-Sacristán A; Fernández-Nestosa MJ; Hernández P; Schvartzman JB; Krimer DB
Cell Res; 2005 Jul; 15(7):495-503. PubMed ID: 16045812
[TBL] [Abstract][Full Text] [Related]
53. Whole transcriptome sequencing and integrated network analysis elucidates the effects of 3,8-Di-O-methylellagic acid 2-O-glucoside derived from Sanguisorba offcinalis L., a novel differentiation inducer on erythroleukemia cells.
Long W; Liu S; Li XX; Shen X; Zeng J; Luo JS; Li KR; Wu AG; Yu L; Qin DL; Hu GQ; Yang J; Wu JM
Pharmacol Res; 2021 Apr; 166():105491. PubMed ID: 33582247
[TBL] [Abstract][Full Text] [Related]
54. Altered expression of beta-globin, transferrin receptor, and ornithine decarboxylase in Friend murine erythroleukemia cells inhibited by alpha-difluoromethylornithine.
Klinken SP; Billelo J; Bauer S; Morse HC; Thorgeirsson SS
Cancer Res; 1987 May; 47(10):2638-44. PubMed ID: 2436752
[TBL] [Abstract][Full Text] [Related]
55. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation.
Marks PA; Ramsay R; Sheffery M; Rifkind RA
Prog Clin Biol Res; 1987; 251():253-68. PubMed ID: 3481077
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of a Src homology 2 domain containing protein tyrosine phosphatase by vanadate in the primary culture of hepatocytes.
Pugazhenthi S; Tanha F; Dahl B; Khandelwal RL
Arch Biochem Biophys; 1996 Nov; 335(2):273-82. PubMed ID: 8914924
[TBL] [Abstract][Full Text] [Related]
57. Modulation of cyclin D1 and its signaling components by the phorbol ester TPA and the tyrosine phosphatase inhibitor vanadate.
Yan S; Wenner CE
J Cell Physiol; 2001 Mar; 186(3):338-49. PubMed ID: 11169972
[TBL] [Abstract][Full Text] [Related]
58. Nuclear but not cytoplasmic phospholipase C beta 1 inhibits differentiation of erythroleukemia cells.
Matteucci A; Faenza I; Gilmour RS; Manzoli L; Billi AM; Peruzzi D; Bavelloni A; Rhee SG; Cocco L
Cancer Res; 1998 Nov; 58(22):5057-60. PubMed ID: 9823310
[TBL] [Abstract][Full Text] [Related]
59. Blockade of murine erythroleukemia cell differentiation by hypomethylating agents causes accumulation of discrete small poly(A)- RNAs hybridized to 3'-end flanking sequences of beta(major) globin gene.
Vizirianakis IS; Tsiftsoglou AS
Biochim Biophys Acta; 2005 Mar; 1743(1-2):101-14. PubMed ID: 15777845
[TBL] [Abstract][Full Text] [Related]
60. Studies of the differentiation properties of camptothecin in the human leukaemic cells K562.
McSheehy PM; Gervasoni M; Lampasona V; Erba E; D'Incalci M
Eur J Cancer; 1991; 27(11):1406-11. PubMed ID: 1660292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
